A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Conditions
HIV
What is the purpose of this trial?
To evaluate the effect of Cobicistat containing regimens on renal parameters.
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Gilead Sciences
- Dates:
- February 2012
- Last Updated:
- Study HIC#:
- 1105008478
Clinicaltrials.gov ID: Yale4313884
